MiRNAs in circulation: Mirroring bone conditions?

Journal of Bone and Mineral Research

Volumn 29, Issue 8, 2014, Pages 1715-1717

  Huang, Jian ^a   Chen, Di ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; ARGONAUTE 2 PROTEIN; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; DICER; MICRORNA; MICRORNA 100; MICRORNA 122A; MICRORNA 124A; MICRORNA 125B; MICRORNA 140; MICRORNA 148A; MICRORNA 21; MICRORNA 23A; MICRORNA 24; MICRORNA 93; PROCOLLAGEN TYPE 1 AMINO TERMINAL PROPEPTIDE; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

APOPTOSIS; BONE DENSITY; BONE REMODELING; BONE TISSUE; CARTILAGE CELL; CIRCULATION; DOWN REGULATION; EXOSOME; FRAGILITY FRACTURE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; MEMBRANE VESICLE; NOTE; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; BLOOD; BONE; PATHOPHYSIOLOGY;

BONE AND BONES; HUMANS; MICRORNAS; OSTEOPOROTIC FRACTURES;

EID: 84904657089     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2297     Document Type: Note

References (36)

1. Kanis JA., Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002; 359 (9321): 1929-36.
2. Marshall D, Johnell O, Wedel H., Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996; 312 (7041): 1254-9.
3. Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A., Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone. 2002; 30 (1): 251-8.
4. Kanis JA, McCloskey EV, Johansson H, Oden A, Strom O, Borgstrom F., Development and use of FRAX in osteoporosis. Osteoporos Int. 2010; 21 (Suppl 2): S407-13.
5. Seeliger C, Karpinski K, Haug A, et al. Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures. J Bone Miner Res. 2014; 29: 1718-28.
6. Yang N, Wang G, Hu C, et al. Tumor necrosis factor alpha suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis. J Bone Miner Res. 2013; 28 (3): 559-73.
7. Hassan MQ, Gordon JA, Beloti MM, et al. A network connecting Runx2, SATB2, and the miR-23a27a 24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci U S A. 2010; 107 (46): 19879-84.
8. Zeng Y, Qu X, Li H, et al. MicroRNA-100 regulates osteogenic differentiation of human adipose-derived mesenchymal stem cells by targeting BMPR2. FEBS Lett. 2012; 586 (16): 2375-81.
9. Mizuno Y, Yagi K, Tokuzawa Y, et al. miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun. 2008; 368 (2): 267-72.
10. Bartel DP., MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136 (2): 215-33.
11. Krol J, Loedige I, Filipowicz W., The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11 (9): 597-610.
12. Kobayashi T, Lu J, Cobb BS, et al. Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proc Natl Acad Sci U S A. 2008; 105 (6): 1949-54.
13. Gaur T, Hussain S, Mudhasani R, et al. Dicer inactivation in osteoprogenitor cells compromises fetal survival and bone formation, while excision in differentiated osteoblasts increases bone mass in the adult mouse. Dev Biol. 2010; 340 (1): 10-21.
14. Harfe BD, McManus MT, Mansfield JH, Hornstein E, Tabin CJ., The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc Natl Acad Sci U S A. 2005; 102 (31): 10898-903.
15. Mizoguchi F, Izu Y, Hayata T, et al. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption. J Cell Biochem. 2010; 109 (5): 866-75.
16. Miyaki S, Sato T, Inoue A, et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 2010; 24 (11): 1173-85.
17. Nakamura Y, Inloes JB, Katagiri T, Kobayashi T., Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling. Mol Cell Biol. 2011; 31 (14): 3019-28.
18. Huang J, Zhao L, Xing L, Chen D., MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells. 2010; 28 (2): 357-64.
19. Li Z, Hassan MQ, Volinia S, et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A. 2008; 105 (37): 13906-11.
20. Zhang Y, Xie RL, Croce CM, et al. A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci U S A. 2011; 108 (24): 9863-8.
21. Goettsch C, Rauner M, Pacyna N, Hempel U, Bornstein SR, Hofbauer LC., miR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol. 2011; 179 (4): 1594-600.
22. Yang L, Cheng P, Chen C, et al. miR-93/Sp7 function loop mediates osteoblast mineralization. J Bone Miner Res. 2012; 27 (7): 1598-606.
23. Zhang JF, Fu WM, He ML, et al. MiR-637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix. Mol Biol Cell. 2011; 22 (21): 3955-61.
24. Chim SS, Shing TK, Hung EC, et al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem. 2008; 54 (3): 482-90.
25. Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 2008; 141 (5): 672-5.
26. Hanson EK, Lubenow H, Ballantyne J., Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. Anal Biochem. 2009; 387 (2): 303-14.
27. Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010; 56 (11): 1733-41.
28. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008; 105 (30): 10513-8.
29. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9 (6): 654-9.
30. Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One. 2008; 3 (11): e3694.
31. Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009; 2 (100): ra81.
32. Turchinovich A, Weiz L, Langheinz A, Burwinkel B., Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011; 39 (16): 7223-33.
33. Nam EJ, Yoon H, Kim SW, et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008; 14 (9): 2690-5.
34. Eastell R, Christiansen C, Grauer A, et al. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. J Bone Miner Res. 2011; 26 (3): 530-7.
35. Seibel MJ., Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev. 2005; 26 (4): 97-122.
36. Williams Z, Ben-Dov IZ, Elias R, et al. Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc Natl Acad Sci U S A. 2013; 110 (11): 4255-60.